Article info
PDFLetters
Lymphangioleiomyomatosis—presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets
- Correspondence to:
Dr H Watz
Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, D-22927 Grosshansdorf, Germany;h.watz{at}pulmoresearch.de
Citation
Lymphangioleiomyomatosis—presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets
Publication history
- First published May 29, 2007.
Online issue publication
September 01, 2022
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 Thorax